Ingvild Nordoy
Overview
Explore the profile of Ingvild Nordoy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
354
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Helset E, Cheng V, Sporsem H, Thorstensen C, Nordoy I, Gammelsrud K, et al.
Acta Anaesthesiol Scand
. 2024 Jan;
68(4):502-511.
PMID: 38286568
Background: Several studies report lack of meropenem pharmacokinetic/pharmacodynamic (PK/PD) target attainment (TA) and risk of therapeutic failure with intermittent bolus infusions in intensive care unit (ICU) patients. The aim of...
2.
De Bortoli A, Nordoy I, Connelly J, Viermyr H, Bjerkreim R, Broch K, et al.
Int J Cardiol
. 2024 Jan;
400:131809.
PMID: 38272129
Background: Evidence-based guidelines for cardiac sarcoidosis (CS) regarding use of second- and third-line agents, treatment duration, surveillance and prognostic factors are lacking. Objective: To analyze the clinical presentation, diagnostics, treatment,...
3.
Andersen I, Reims H, Grzyb K, Fevang B, Melum E, Aukrust P, et al.
Liver Transpl
. 2023 Mar;
29(8):894-899.
PMID: 36932715
No abstract available.
4.
Fraz M, Dahle G, Skaug K, Jarraud S, Frye S, Bjornholt J, et al.
Front Med (Lausanne)
. 2022 Nov;
9:1055465.
PMID: 36405607
Extrapulmonary infections with are rare, but important to acknowledge. We report a case of infective endocarditis (IE) with in a 66-year-old immunocompetent man with an aortic homograft. The diagnosis was...
5.
Fraz M, Michelsen A, Moe N, Aalokken T, Macpherson M, Nordoy I, et al.
J Clin Immunol
. 2022 Jul;
42(7):1553-1563.
PMID: 35789314
Purpose: About 20-30% of patients with common variable immunodeficiency (CVID) develop granulomatous-lymphocytic interstitial lung disease (GLILD) as one of several non-infectious complications to their immunodeficiency. The purpose of this study...
6.
Sovik S, Barrat-Due A, Kasine T, Olasveengen T, Strand M, Tveita A, et al.
J Infect
. 2022 May;
85(1):57-63.
PMID: 35605805
Objectives: To determine the incidence and characteristics of superinfections in mechanically ventilated COVID-19 patients, and the impact of dexamethasone as standard therapy. Methods: This multicentre, observational, retrospective study included patients...
7.
Jorgensen S, Buechner J, Myhre A, Galteland E, Spetalen S, Kulseth M, et al.
J Clin Immunol
. 2021 Dec;
42(2):404-420.
PMID: 34893945
Purpose: GATA2 deficiency is a rare primary immunodeficiency that has become increasingly recognized due to improved molecular diagnostics and clinical awareness. The only cure for GATA2 deficiency is allogeneic hematopoietic...
8.
Hustad N, Degerud H, Hjelmerud I, Fraz M, Nordoy I, Troseid M, et al.
Front Immunol
. 2021 May;
12:670547.
PMID: 34012453
Immunoglobulin replacement therapy with facilitated subcutaneous immunoglobulin (fSCIg) can be self-administrated at home and given at longer intervals compared to subcutaneous immunoglobulin (SCIg) therapy, but real-word experience of home-based fSCIg...
9.
Fraz M, Moe N, Revheim M, Stavrinou M, Durheim M, Nordoy I, et al.
Front Immunol
. 2021 Feb;
11:617985.
PMID: 33584710
Conclusion: Patients with progressive GLILD as defined by deteriorating pulmonary function had significantly greater pathology on pulmonary CT and FDG-PET CT scans as compared to patients with stable disease, with...
10.
Bjorkto M, Barratt-Due A, Nordoy I, Dorje C, Galteland E, Lind A, et al.
BMC Infect Dis
. 2021 Feb;
21(1):137.
PMID: 33526010
Background: The use of complement inhibition is well established for complement mediated thrombotic microangiopathy, but its role in secondary forms of thrombotic microangiopathy is debated. We here present a case...